Four scenarios for digital therapeutics, on a 10-year horizon.
UCB Biopharma · Global R&D Strategy
UCB needed a defensible framework to prioritize R&D investment under deep uncertainty about how AI will reshape healthcare. The brief was a single question: how will AI reshape healthcare consumption in the next 10 years?
Leading the foresight methodology across a UCB and Bakery team, we built a Python script to run a systematic literature review on 1,200+ academic papers, triangulated against 300+ news items, 40+ business reports, and 30+ interviews with patients, physicians, and pharma leaders.
We identified 15 megatrends, refined them to 6, then to 2 complementary lenses: Patient Empowerment and R&D Speed. Crossing the lenses on a 2x2 matrix produced four 10-year scenarios, each with named consumer behaviors, North Star metrics, AI healthcare journeys, and benchmarks of who is preparing today.
The framework was extended into a regional intelligence engine for UCB Germany, translating the global megatrends to a structured local signal-monitoring framework.
We added an outside-in layer to UCB's strategic planning, naming the digital capabilities that keep the company's strategic edge across whichever scenario lands.